Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

被引：0

作者：

Lukas Donix

Holger H. H. Erb

Claudia Peitzsch

Anna Dubrovska

Manuel Pfeifer

Christian Thomas

Susanne Fuessel

Kati Erdmann

机构：

[1] Technische Universität Dresden,Department of Urology, Faculty of Medicine

[2] National Center for Tumor Diseases (NCT),National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine

[3] Dresden,Helmholtz

[4] Germany: German Cancer Research Center (DKFZ),Zentrum Dresden

[5] Heidelberg,Rossendorf

[6] Germany; Faculty of Medicine and University Hospital Carl Gustav Carus,Institute of Legal Medicine, Faculty of Medicine

[7] Technische Universität Dresden,undefined

[8] Dresden,undefined

[9] Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR),undefined

[10] Technische Universität Dresden,undefined

[11] Institute of Radiooncology - OncoRay,undefined

[12] German Cancer Consortium (DKTK),undefined

[13] Partner Site Dresden,undefined

[14] Dresden and German Cancer Research Center (DKFZ),undefined

[15] Technische Universität Dresden,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Cisplatin; Docetaxel; mCRPC; NEPC; Prostate cancer; Radiotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1313 / 1324

页数：11

共 50 条

[31] Lack of cross-resistance to erlotinib in human head and neck cancer cells with acquired resistance to cetuximab
Bonner, J. A.
Xing, C.
Trummell, H.
ANNALS OF ONCOLOGY, 2023, 34 : S1618 - S1619
[32] DETERMINATION OF ACQUIRED DRUG-RESISTANCE AND CROSS-RESISTANCE IN HEMATOLOGICAL MALIGNANCIES
BOSANQUET, AG
BIRD, MC
FORSKITT, S
GILBY, ED
BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (03) : 620 - 621
[33] Acquired resistance to sulphasalazine can confer marked cross-resistance to methotrexate
Jansen, G
van der Heijden, J
Lems, WF
Ifergan, I
Scheper, RJ
Assaraf, YG
Dijkmans, BAC
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 204 - 204
[34] RON and Cisplatin Resistance in Ovarian Cancer Cell Lines
Prislei, Silvia
Mariani, Marisa
Raspaglio, Giuseppina
Mozzetti, Simona
Filippetti, Flavia
Ferrandina, Gabriella
Scambia, Giovanni
Ferlini, Cristiano
ONCOLOGY RESEARCH, 2010, 19 (01) : 13 - 22
[35] CROSS-RESISTANCE IN CELL-LINES OF NICOTIANA-SYLVESTRIS SELECTED FOR RESISTANCE TO INDIVIDUAL ANTIBIOTICS
DIX, PJ
ANNALS OF BOTANY, 1981, 48 (03) : 321 - 325
[36] Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines
Keshelava, N
Grosheu, S
Reynolds, CP
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (01) : 1 - 8
[37] Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines
Nino Keshelava
Susan Groshen
C. Patrick Reynolds
Cancer Chemotherapy and Pharmacology, 2000, 45 : 1 - 8
[38] Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
Pu, YS
Chen, J
Huang, CY
Guan, JY
Lu, SH
Hour, TC
JOURNAL OF UROLOGY, 2001, 165 (06): : 2082 - 2085
[39] KIF14 mediates cabazitaxel-docetaxel cross-resistance in advanced prostate cancer by promoting AKT phosphorylation
Liu, Lina
Li, Mengyuan
Zhang, Junshuo
Xu, Dengfei
Guo, Yan
Zhang, Hui
Cang, Shundong
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 737
[40] Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs
Choudhuri, Shreoshi Pal
Girard, Luc
Lim, Jun Yi Stanley
Wise, Jillian F.
Freitas, Braeden
Yang, Di
Wong, Edmond
Hamilton, Seth
Chien, Victor D.
Kim, Yoon Jung
Gilbreath, Collin
Zhong, Jun
Phat, Sarah
Myers, David T.
Christensen, Camilla L.
Mazloom-Farsibaf, Hanieh
Stanzione, Marcello
Wong, Kwok-Kin
Hung, Yin P.
Farago, Anna F.
Meador, Catherine B.
Dyson, Nicholas J.
Lawrence, Michael S.
Wu, Sihan
Drapkin, Benjamin J.
CANCER DISCOVERY, 2024, 14 (05) : 804 - 827

← 1 2 3 4 5 →